Please login to the form below
Peru
This page shows the latest Peru news and features for those working in and with pharma, biotech and healthcare.
CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
Another phase 2a in Peru and Panama has also completed recruitment with 674 participants.
Latest news
-
CureVac expands COVID-19 vaccine trial protocol to include variant specification
In addition, for the company’s phase 2a dose-confirmation trial in older adults in Peru and Panama, CureVac has now submitted a protocol amendment to include a secondary objective for
-
Questions surrounding remdesivir treatment for COVID-19 are ‘complicated’, says NEJM
The Solidary trial also took place across a number of different countries including Canada, France and Switzerland, as well as Peru, the Philippines and South Africa.
-
The Global Awards 2016 finalists announced
Seiden. Serviceplan Health and Life. Sudler London. Tank. Tazefikir. TBWA Perú.
-
Gilead's Truvada cleared for HIV prevention in EU
The drug is also approved for PrEP in Australia, Canada, Kenya, Peru and South Africa.
-
Daiichi Sankyo collaborates on e-patient AF resource
2014. In 2015 the company opened its online doors in the US and its future plans include dedicated sites for Mexico, Argentina, Colombia, Peru and Chile. .
More from news
Approximately 1 fully matching, plus 14 partially matching documents found.
Latest Intelligence
-
Safe from harm?
Across the world, attitudes towards healthcare decision-making vary substantially. Peru (75%), Bolivia (75%), Egypt (71%) and Chile (66%) are the countries where physicians are most likely to make treatment decisions.
-
Current development and marketing of biosimilar monoclonal antibodies in Latin America
Market. Marketed in Chile, Ecuador, Peru and Paraguay. (1). CF Recalcine (Chile). ... 5) Partnership with Human Bioscience established on July 2012 for commercialization in Colombia, Venezuela, Ecuador and Peru.}.
-
Unfolding the biosimilar landscape in Latin America
Countries like Colombia, which is on the cusp of publishing its guidelines, Venezuela, Peru or Ecuador have yet to reach a similar development status, while some smaller countries have yet to ... In Latin America, this includes countries like Brazil,
-
Positive prospects for pharma in Latin America
Espicom Business Intelligence predicts that the region's eight major markets — Brazil, Mexico, Argentina, Chile, Colombia, Cuba, Peru and Venezuela — will represent a retail value of $80bn in 2013, up from ... In Mexico, Venezuela and Peru, public
-
Interview with Roch Doliveux, UCB
He joined the pharmaceutical industry early in his career, first at Ciba-Geigy (now Novartis) in Switzerland, Peru and France.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Porterhouse announces members of medical advisory group
In addition to her education experience, Daoud has undertaken volunteering work in China and Peru, and completed her medical elective in Nepal, where she worked in a primary healthcare centre in
-
Oscar Ferenczi joins Grünenthal from Sandoz
Prior to this period, he spent more than at decade at Merck &Co in the region, including spells as general manager Ecuador, general manager Peru, general manager Chile, and VP and
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Introducing the members of the Porterhouse Medical Advisory Group
Natasha has undertaken volunteering work in China and Peru, and completed her medical elective in Nepal, where she worked in a primary healthcare centre in Kathmandu.
-
Porterhouse Medical Group boosts its scientific services team with two new appointments
Natasha has a passion for travel, having volunteered in China and Peru, and having completed her medical elective in Nepal, working in a primary healthcare centre in Kathmandu.
-
Good intentions, bad habits: Reforming mental healthcare in Latin America and the Caribbean
The diversity is also economic. Recent years have seen marked improvements in income distribution and a burgeoning middle class, particularly in countries such as Argentina, Bolivia, Ecuador, Peru and Nicaragua.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models
- World Cancer Day: encouraging men to put their health first
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Strategic behaviour
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Creabilis names Catherine Moukheibir as chairman of the board
- World Health Organization releases latest set of COVID-19 guidelines
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- MIT researchers develop AI model to detect future lung cancer risk
PMHub
Langland
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
